Montenegro vs South Sudan: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Montenegro
28.0%
in 2025
South Sudan
27.0%
in 2025
Montenegro rank
162nd
South Sudan rank
163rd
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Montenegro
- South Sudan
How they compare
Montenegro currently reports 28.0% against 27.0% in South Sudan, a difference of 1.0%.
The two have swapped places 1 time across 15 shared years of data; in 2011 it was South Sudan ahead.
Montenegro ranks 162nd and South Sudan ranks 163rd of 194 countries.
Montenegro has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Montenegro | South Sudan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.0% | 0.0% | 0.0% | — |
| 2020s | 4.7% | 4.5% | 0.2% | Montenegro |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Montenegro or South Sudan?
- Montenegro, at 28.0% against 27.0% in South Sudan as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Montenegro and South Sudan?
- 1.0%, with Montenegro ahead.
- How many years of comparable data are there for Montenegro and South Sudan?
- 15 years are reported by both, from 2011 to 2025.
- How do Montenegro and South Sudan rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Montenegro ranks 162nd and South Sudan ranks 163rd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.